Lv01
0 积分 2024-08-04 加入
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
4小时前
已完结
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
5小时前
已完结
Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts
22天前
已完结
The impact of artificial liver support system on intestinal microbiota and serum bile acid profiles in patients with acute-on-chronic liver failure: a prospective cohort study
22天前
已完结
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
1个月前
已完结
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
1个月前
已完结
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
1个月前
已完结
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
1个月前
已完结
Simvastatin and Rifaximin in Decompensated Cirrhosis
1个月前
已完结
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial
1个月前
已完结
皖公网安备34019202002308
